|
⚲
|
| Keyboard |
| Friedli Peter
✚
|
|
|---|---|
| CIK # | 0001008317 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001008317] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Osiris Therapeutics Inc | |
| Friedli Peter |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Osiris Therapeutics Inc OSIR
Common Stock
|
2019-04-17 | Disposed to issuer | 10,204,404 | $19.00 | 193,883,676 |
|
Osiris Therapeutics Inc OSIR
Common Stock
|
2019-04-17 | Disposed to issuer | 500,000 | $19.00 | 9,500,000 |
|
Osiris Therapeutics Inc OSIR
Common Stock
|
2019-04-17 | Disposed to issuer | 4,103,301 | $19.00 | 77,962,719 |
|
Osiris Therapeutics Inc OSIR
Common Stock
|
2019-04-17 | Disposed to issuer | 2,750 | $19.00 | 52,250 |
|
Osiris Therapeutics Inc OSIR
Common Stock
|
2014-02-06 | Grant | 10,000 | $14.93 | 149,300 |
|
Osiris Therapeutics Inc OSIR
Common Stock
|
2014-01-17 | Other | 0 | ||
|
Osiris Therapeutics Inc OSIR
Common Stock
|
2013-08-14 | Tax withheld | 432,390 | $25.44 | 11,000,002 |
|
Osiris Therapeutics Inc OSIR
Common Stock
|
2013-08-14 | Option exercise | 1,000,000 | $11.00 | 11,000,000 |
|
Osiris Therapeutics Inc OSIR
Common Stock Purchase Warrant · derivative
|
2013-08-14 | Option exercise | 1,000,000 | $0.00 | |
|
Osiris Therapeutics Inc OSIR
Common Stock
|
2013-02-12 | Grant | 10,000 | $7.73 | 77,300 |
|
Osiris Therapeutics Inc OSIR
Common Stock
|
2012-12-10 | Sell | 50,000 | $9.52 | 476,000 |
|
Osiris Therapeutics Inc OSIR
Common Stock
|
2012-11-15 | Sell | 625 | $9.34 | 5,838 |
|
Osiris Therapeutics Inc OSIR
Common Stock
|
2012-03-23 | Grant | 10,000 | $5.08 | 50,800 |